NeOnc Technologies Holdings, Inc. (NTHI)
8.37
+0.10
(+1.21%)
USD |
NASDAQ |
Jan 02, 14:06
NeOnc Technologies Holdings Research and Development Expense (Annual): 3.045M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Synergy CHC Corp. | -- |
| Acurx Pharmaceuticals, Inc. | 5.404M |
| NRX Pharmaceuticals, Inc. | 6.199M |
| Sharps Technology, Inc. | -0.058M |
| CEL-SCI Corp. | 15.89M |